3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Stress Disorders, Post-Traumatic
1
Sleep Initiation and Maintenance Disorders
1
Sleep Disorders, Circadian Rhythm
1
Sleep Deprivation
1
REM Sleep Behavior Disorder
1
Psychological Well-Being
1
Pain
1
Leukemia
1
Idiopathic Hypersomnia
1
Depression
1
Combat Disorders
1
Chronobiology Disorders
1
Cancer Pain
1
Anxiety Disorders
1
Alzheimer Disease
1
Interventions
Oxycodone
9
Fentanyl
6
Morphine
4
resiniferatoxin
3
nabiximols
3
Naloxone
2
Dronabinol
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tanezumab
1
rofecoxib
1
naloxegol
1
fulranumab
1
cannabichromene
1
alvimopan
1
Venlafaxine Hydrochloride
1
Ultracet
1
Tapentadol
1
Standard of Care
1
Radiation
1
Propofol
1
Nerve Growth Factor
1
Methadone
1
Memantine
1
Inosine Monophosphate
1
Hydromorphone
1
Electroencephalography
1
Duration of Therapy
1
Cannabidiol
1
Antibodies
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Cancer Pain
×
Propofol
×
Clear all
NCT06644573
2025-05-28
PSHW
PROSOMNIA Sleep Health & Wellness
Phase 1
Not yet recruiting
100 enrolled